Kadcyla (trastuzumab emtansine)
Kadcyla (trastuzumab emtansine) has two active components (a monoclonal antibody and DM1, a toxic substance) indicated for the treatment of patients with HER2-positive metastatic and/or early breast cancer (MBC and EBC). This is only indicated for patients who have received previous therapies. See the clinical trials tab.
Kadcyla is indicated by the FDA for patients who previously received trastuzumab and a taxane, separately or in combination. Patients should have either:
received prior therapy for metastatic disease, or
developed disease recurrence during or within six months of completing adjuvant therapy.
This medicine is not (yet) part of our standard product range but we may be able to get it for you. The packaging size and strength below may vary due to product availability. Please contact us to verify price and availability.
Medicine approved by
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Therapeutic Goods Administration (TGA)
- Over 1 million patients reached
- Over 11,000 patients helped
- 6,000 medicines supplied
- 100% success delivering to people in 75 countries
Safe and Secure
“I want to recommend everyone to work with this organization. They are reliable, honest, punctual and do everything to meet your needs…”
“Dr. Aysen Simsek and her team offered assistance during a very difficult time. I truly appreciate their quick, efficient and professional attitude, as well as their patience and superb customer service…”
“I highly recommend TheSocialMedwork. They welcomed me with open arms when I went to their office in Amsterdam. I was in a very difficult situation with a tight schedule, and their amazing team members…”
We offer a world-first service for people with serious conditions who need access to the latest medicines. Our global service enables you to buy new medications that are not yet available in your own country. We ship these medicines directly to you, your hospital or pharmacy, or you can pick them up at our pharmacy in Amsterdam.Learn more
Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Medicine information contained herein may be time sensitive. The absence of a warning for a given medicine or combination thereof in no way should be construed to indicate that the medicine or combination is safe, effective or appropriate for any given patient. Always consult your treating physician before starting a course of treatment.